TrialBlood2017
Venetoclax and obinutuzumab in chronic lymphocytic leukemia.
Kirsten Fischer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
59 papers cite it
this paperpooled ittrialcites it
TrialBlood2017
Kirsten Fischer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.